Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2026-02-03 @ 1:59 AM
Study NCT ID:
NCT02152995
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-15
First Post:
2014-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Thyroid Gland Carcinoma | View |
| None | Poorly Differentiated Thyroid Gland Carcinoma | View |
| None | Recurrent Thyroid Gland Carcinoma | View |
| None | Refractory Thyroid Gland Carcinoma | View |
| None | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | View |
| None | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | View |
| None | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | View |
| None | Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 | View |
| None | Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 | View |
| None | Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 | View |
| None | Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 | View |
| None | Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 | View |
Keywords: